Literature DB >> 25809639

Safety and efficacy of blood exchange transfusion for priapism complicating sickle cell disease.

Samir K Ballas1, David Lyon1.   

Abstract

BACKGROUND: Priapism is unwanted painful penile erection that affects about 36% of boys and men with sickle cell disease (SCD) most of whom have sickle cell anemia. Clinically, priapism could be stuttering, minor, or major. The first two types are mild, last < 4 h, are usually treated at home, have good prognosis with normal sexual function. The major type of priapism lasts >4 h, associated with severe pain, requires hospitalization; often does not respond to medical treatment and may require shunt surgery. Untreated major priapism and surgical intervention often cause impotence. In this study, we report our 15-year experience in treating adult patients with SCD and major priapism with blood exchange transfusion after being refractory to other medical therapies.
METHODS: Adult male African Americans patients with SCD and major priapism were enrolled in this study and followed for 15 years. A Haemonitics V-50 machine was initially used for whole blood exchange and was later replaced with Cobe Spectra machine for RBC exchange.
RESULTS: We used 239 blood exchanges requiring 1,136 RBC units. We maintained a post-exchange hemoglobin level of about 10 g/dL and hemoglobin S level < 30%. None of the patients had any neurological complications such as headache, seizures, neurological deficits, or obtundation post-exchange.
CONCLUSION: Together, the data indicate that blood exchange transfusion for the treatment of patients with SCD and major priapism is efficacious and safe.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  impotence; neurological complications; safety; shunt surgery

Mesh:

Substances:

Year:  2015        PMID: 25809639     DOI: 10.1002/jca.21394

Source DB:  PubMed          Journal:  J Clin Apher        ISSN: 0733-2459            Impact factor:   2.821


  10 in total

1.  Resolution of Acute Priapism in Two Children With Sickle Cell Disease Who Received Nitrous Oxide.

Authors:  Michael H Greenwald; Colleen K Gutman; Claudia R Morris
Journal:  Acad Emerg Med       Date:  2019-08-01       Impact factor: 3.451

Review 2.  Sickle cell disease: when and how to transfuse.

Authors:  Jo Howard
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 3.  Medical and economic implications of strategies to prevent alloimmunization in sickle cell disease.

Authors:  Eric A Gehrie; Paul M Ness; Evan M Bloch; Seema Kacker; Aaron A R Tobian
Journal:  Transfusion       Date:  2017-06-26       Impact factor: 3.157

Review 4.  Treatment dilemmas: strategies for priapism, chronic leg ulcer disease, and pulmonary hypertension in sickle cell disease.

Authors:  Roberta C G Azbell; Payal Chandarana Desai
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

Review 5.  What is the effectiveness of surgical and non-surgical therapies in the treatment of ischemic priapism in patients with sickle cell disease? A systematic review by the EAU Sexual and Reproductive Health Guidelines Panel.

Authors:  S Minhas; A Salonia; M Gül; B Luca; K Dimitropoulos; P Capogrosso; U Milenkovic; A Cocci; R Veeratterapillay; G Hatzichristodoulou; V Modgil; G I Russo; T Tharakan; A Kalkanli; M I Omar; C Bettocchi; J Carvalho; G Corona; T H Jones; A Kadioglu; J I Martinez-Salamanca; E C Serefoglu; P Verze
Journal:  Int J Impot Res       Date:  2022-08-08       Impact factor: 2.408

6.  Stuttering priapism in a patient with sickle cell trait treated with automated red cell exchange transfusion.

Authors:  Mohammad S Ebraheem; Madeleine Verhovsek
Journal:  Blood Adv       Date:  2021-12-14

Review 7.  State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.

Authors:  Latika Puri; Kerri A Nottage; Jane S Hankins; Doralina L Anghelescu
Journal:  Paediatr Drugs       Date:  2018-02       Impact factor: 3.022

8.  Treatments for priapism in boys and men with sickle cell disease.

Authors:  Francis I Chinegwundoh; Sherie Smith; Kofi A Anie
Journal:  Cochrane Database Syst Rev       Date:  2020-04-06

9.  Efficacy and Safety of Manual Partial Red Cell Exchange in the Management of Severe Complications of Sickle Cell Disease in a Developing Country.

Authors:  B F Faye; D Sow; M Seck; N Dieng; S A Toure; M Gadji; A B Senghor; Y B Gueye; D Sy; A Sall; T N Dieye; A O Toure; S Diop
Journal:  Adv Hematol       Date:  2017-05-11

10.  Priapism in sickle cell disease: Associations between NOS3 and EDN1 genetic polymorphisms and laboratory biomarkers.

Authors:  Camylla Vilas Boas Figueiredo; Rayra Pereira Santiago; Caroline Conceição da Guarda; Rodrigo Mota Oliveira; Luciana Magalhães Fiuza; Sètondji Cocou Modeste Alexandre Yahouédéhou; Suéllen Pinheiro Carvalho; Joelma Santana Dos Santos Neres; Antonio Mateus de Jesus Oliveira; Cleverson Alves Fonseca; Valma Maria Lopes Nascimento; Isa Menezes Lyra; Milena Magalhães Aleluia; Marilda Souza Goncalves
Journal:  PLoS One       Date:  2021-02-04       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.